Steve Berman (lawyer)

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages F45 Training Holdings (FXLV) Investors with Losses to Contact Firm’s Attorneys, Securities Class Action Pending

Retrieved on: 
Tuesday, January 17, 2023
SAN, News, Steve Berman (lawyer), IPO, Person, NYSE, Security (finance), Renewable energy, Pharmaceutical industry, F45

SAN FRANCISCO, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges F45 Training Holdings, Inc. (NYSE: FXLV) investors who suffered significant losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges F45 Training Holdings, Inc. (NYSE: FXLV) investors who suffered significant losses to submit your losses now .
  • According to the complaint, Defendants made false and misleading statements or failed to disclose in the IPO offering documents material adverse facts about F45’s business, operations, and prospects.
  • If you invested in F45 and have significant losses, or have knowledge that may assist the firm’s investigation, click here to discuss your legal rights with Hagens Berman .
  • Whistleblowers: Persons with non-public information regarding F45 should consider their options to help in the investigation or take advantage of the SEC Whistleblower program.

GNRC 13-DAY DEADLINE ALERT: Hagens Berman Encourages Generac Holdings (GNRC) Investors with Significant Losses to Contact Firm’s Attorneys Before Jan. 30th Deadline in Securities Class Action

Retrieved on: 
Tuesday, January 17, 2023
Safety, Person, NYSE, Steve Berman (lawyer), Bankruptcy, SAN, Book, GNRC, Electricity, Renewable energy, Pharmaceutical industry, Generac Holdings

SAN FRANCISCO, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Generac Holdings Inc. (NYSE: GNRC) investors who suffered significant losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Generac Holdings Inc. (NYSE: GNRC) investors who suffered significant losses to submit your losses now .
  • Each of these disclosures caused the price of Generac shares to decline sharply, thereby injuring investors.
  • “We’re focused on investors’ losses and proving Generac cooked its books,” said Reed Kathrein, the Hagens Berman partner leading the investigation.
  • If you invested in Generac and have significant losses, or have knowledge that may assist the firm’s investigation, click here to discuss your legal rights with Hagens Berman .

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Twist Bioscience (TWST) Investors with Losses to Contact Firm’s Attorneys, Securities Fraud Class Action Pending

Retrieved on: 
Tuesday, January 17, 2023
Public expenditure, DNA, Person, Growth, Steve Berman (lawyer), Scorpion, Complaint, SAN, Charles Ponzi, Fraud, Private investigator, Pharmaceutical industry

SAN FRANCISCO, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Twist Bioscience Corporation (NASDAQ: TWST) investors who suffered significant losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Twist Bioscience Corporation (NASDAQ: TWST) investors who suffered significant losses to submit your losses now .
  • “We’re focused on investors’ losses and proving Twist lied about its technology and true financial performance,” said Reed Kathrein, the Hagens Berman partner leading the investigation.
  • If you invested in Twist and have significant losses, or have knowledge that may assist the firm’s investigation, click here to discuss your legal rights with Hagens Berman .
  • Whistleblowers: Persons with non-public information regarding Twist should consider their options to help in the investigation or take advantage of the SEC Whistleblower program.

PHI ALERT: Hagens Berman, National Trial Attorneys, Encourages Investors With Significant Losses in PLDT Inc. (PHI) to Contact Firm’s Attorneys, Firm Investigating Possible Securities Law Violations

Retrieved on: 
Tuesday, January 17, 2023
Public expenditure, PLDT, Inquirer, SGV, Pangilinan, Internet, Person, The Philadelphia Inquirer, NYSE, Steve Berman (lawyer), PHI, Philippine Daily Inquirer, SAN, P130, Cryptocurrency, Pharmaceutical industry

SAN FRANCISCO, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges PLDT Inc. (NYSE: PHI) investors who suffered significant losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges PLDT Inc. (NYSE: PHI) investors who suffered significant losses to submit your losses now .
  • More specifically, on Dec. 16, 2022 PLDT announced that during 2019 – 2022 it experienced a budget overrun of approximately P48 billion on its massive network transformation program.
  • “We’re focused on investors’ losses and whether PLDT misled investors about its CAPEX spend associated with its network buildout,” said Reed Kathrein, the Hagens Berman partner leading the investigation.
  • If you invested in PLDT and have significant losses, or have knowledge that may assist the firm’s investigation, click here to discuss your legal rights with Hagens Berman .

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Welltower Inc. (WELL) Investors with Significant Losses to Contact Firm’s Attorneys, Firm Investigating Possible Securities Law Violations

Retrieved on: 
Tuesday, January 17, 2023
ProMedica, Shell, Hindenburg Research, Integra, Person, Research, NYSE, Weakness, WELL, Steve Berman (lawyer), SAN, Research report, Hindenburg, JV, Airline, Pharmaceutical industry, Welltower

SAN FRANCISCO, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Welltower Inc. (NYSE: WELL) investors with significant losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Welltower Inc. (NYSE: WELL) investors with significant losses to submit your losses now .
  • In response, the price of Welltower shares fell as much as $4.18, or down over 6%, during intraday trading on Dec. 7, 2022.
  • “We’re focused on investors’ losses and whether Welltower has concealed weaknesses in its portfolio,” said Reed Kathrein, the Hagens Berman partner leading the investigation.
  • If you invested in Welltower and have significant losses, or have knowledge that may assist the firm’s investigation, click here to discuss your legal rights with Hagens Berman .

CACC ALERT: Hagens Berman, National Trial Attorneys, Encourages Credit Acceptance Corporation (CACC) Investors with Significant Losses to Contact Firm’s Attorneys, Firm Investigating Possible Securities Law Violations

Retrieved on: 
Tuesday, January 17, 2023
News, CACC, Credit, Person, Steve Berman (lawyer), Credit Acceptance, New Yorkers, Consumer Financial Protection Bureau, SAN, NYAG, Consumer, Bank, Risk management

SAN FRANCISCO, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Credit Acceptance Corporation (NASDAQ: CACC) investors who suffered significant losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Credit Acceptance Corporation (NASDAQ: CACC) investors who suffered significant losses to submit your losses now .
  • Credit Acceptance Corporation (CACC) Investigation:
    Credit Acceptance, one of the nation's largest subprime auto lenders, offers financing programs that enable auto dealers to sell vehicles to consumers regardless of their credit history.
  • This news drove the price of Credit Acceptance shares down over 11% on Jan. 4, 2023.
  • If you invested in Credit Acceptance and have significant losses, or have knowledge that may assist the firm’s investigation, click here to discuss your legal rights with Hagens Berman .

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Silvergate Capital (SI) Investors with $200K+ Losses to Contact Firm’s Attorneys, Deadline Approaching in Securities Fraud Class Action

Retrieved on: 
Monday, January 16, 2023
SAN, Bear's Cave (Erpfingen), Research, FTX, Workforce, Bears' Cave, Steve Berman (lawyer), SI, Person, NYSE, Cryptocurrency, Pharmaceutical industry, Silvergate Media

SAN FRANCISCO, Jan. 16, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Silvergate Capital Corporation (NYSE: SI) investors who suffered significant losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, Jan. 16, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Silvergate Capital Corporation (NYSE: SI) investors who suffered significant losses to submit your losses now .
  • Then, on Nov. 17, 2022, analyst The Bear Cave released an article emphasizing Silvergate’s potential exposure to recently collapsed cryptocurrency exchange FTX.
  • “We’re focused on investors’ losses and whether Silvergate misled investors about the sufficiency of its controls to protect deposits from misappropriation,” said Reed Kathrein, the Hagens Berman partner leading the investigation.
  • If you invested in Silvergate and have significant losses, or have knowledge that may assist the firm’s investigation, click here to discuss your legal rights with Hagens Berman .

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Enovix Corporation (ENVX) Investors with Significant Losses to Contact Firm’s Attorneys, Securities Fraud Class Action Pending

Retrieved on: 
Monday, January 16, 2023
Harrold, Silicon, Person, Steve Berman (lawyer), Complaint, SAN, Cybook Gen1, Risk management, Pharmaceutical industry

SAN FRANCISCO, Jan. 16, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Enovix Corporation (NASDAQ: ENVX) investors who suffered significant losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, Jan. 16, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Enovix Corporation (NASDAQ: ENVX) investors who suffered significant losses to submit your losses now .
  • Enovix’s assurances began to come into question on Nov. 1, 2022, when the company announced disappointing Q3 revenues of just $8,000.
  • “We’re focused on investors’ losses and proving Enovix lied about the real Fab-1 and Gen1 capabilities,” said Reed Kathrein, the Hagens Berman partner leading the investigation.
  • If you invested in Enovix and have significant losses, or have knowledge that may assist the firm’s investigation, click here to discuss your legal rights with Hagens Berman .

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Avaya Holdings Corp. (AVYA) Investors with Significant Losses to Contact Firm’s Attorneys, Securities Fraud Class Action Pending

Retrieved on: 
Monday, January 16, 2023
Ethics, Committee, Person, NYSE, Steve Berman (lawyer), AVYA, Audit committee, SAN, Software as a service, Audit, Pharmaceutical industry, Avaya

SAN FRANCISCO, Jan. 16, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Avaya Holdings Corp. (NYSE: AVYA) investors who suffered significant losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, Jan. 16, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Avaya Holdings Corp. (NYSE: AVYA) investors who suffered significant losses to submit your losses now .
  • “We’re focused on investors’ losses and proving Avaya misled investors about its controls and progress of its business model transformation,” said Reed Kathrein, the Hagens Berman partner leading the investigation.
  • If you invested in Avaya and have significant losses, or have knowledge that may assist the firm’s investigation, click here to discuss your legal rights with Hagens Berman .
  • Whistleblowers: Persons with non-public information regarding Avaya should consider their options to help in the investigation or take advantage of the SEC Whistleblower program.

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Veru Inc. (VERU) Investors with Significant Losses to Contact Firm’s Attorneys, Deadline Approaching in Securities Class Action

Retrieved on: 
Monday, January 16, 2023
News, COVID, EUA, FDA, Person, Steve Berman (lawyer), Patient, SAN, COVID 19, Pharmaceutical industry, Verus Pharmaceuticals

SAN FRANCISCO, Jan. 16, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Veru Inc. (NASDAQ: VERU) investors with significant losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, Jan. 16, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Veru Inc. (NASDAQ: VERU) investors with significant losses to submit your losses now .
  • VERU’s filings therefore concealed the true risks faced by the Company in gaining approval for its EUA request.
  • Investors learned the truth on Nov. 9, 2022, when Veru announced that the FDA advisory committee (“AdCom”) voted against approving sabizabulin under the agency’s EUA pathway.
  • If you invested in Veru and have significant losses, or have knowledge that may assist the firm’s investigation, click here to discuss your legal rights with Hagens Berman .